mRNA vaccines: A novel weapon to control infectious diseases
мРНК-вакцины: новое оружие для контроля инфекционных заболеваний
2022-10-04
SCID: 54.1/q24jkfhq
Discuss with AI
SARS-CoV-2infectious diseasesinnate immune responsemRNA vaccinesvaccine delivery systems
Figures from the paper
Abstract (AI)
Infectious diseases have always threatened human life, but with the development of vaccines, effective strategies for preventing and controlling these diseases have become available. The global outbreak of COVID-19 ushered in the advent of mRNA vaccine technologies, which quickly led to the introduction of mRNA vaccines effective against SARS-CoV-2. The success of this approach has stimulated research into the use of mRNA vaccines in the fight against other emerging as well as remerging infectious diseases. This review examines the constructive strategies and delivery systems used in mRNA vaccines and provides an overview of current clinical trials of those vaccines in the prevention of infectious diseases. The underlying mechanisms of mRNA vaccines are also discussed, including the double-edged sword of the innate immune response. Finally, the challenges but also the potential of mRNA vaccines are considered.
Key Findings
1
COVID-19 demonstrated that mRNA vaccine technology can rapidly produce effective vaccines against SARS-CoV-2.
2
Effective mRNA vaccine design depends on constructive strategies and delivery systems that enable therapeutic messenger RNA use.
3
Innate immune activation has a double-edged role in mRNA vaccination, while delivery, safety, and other challenges constrain broader application.
4
The review summarizes current clinical trials evaluating mRNA vaccines for infectious-disease prevention.
5
The success of SARS-CoV-2 mRNA vaccines has accelerated development for emerging and re-emerging infectious diseases.
6
mRNA vaccines show substantial potential as a versatile strategy for controlling infectious diseases.
Research Object
mRNA vaccines for preventing and controlling infectious diseases
Research Subject
vaccine design and delivery strategies, clinical development, mechanisms of action, innate immune responses, challenges, and potential
Publication Details
Publication Date
2022-10-04
Journal
Publisher
ISSN
Cited by
28
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest